Cancer, data and the fallacy of the $1000 genome

d

Here’s Mark’s key message:  The time of the $1000 genome meme is over.  It served us well for years –  driving advances in instrumentation, chemistry and biology.  But now it is reducing clinical credibility.  It’s time for it to leave the lexicon of healthcare; it has to go.

View the original article here: Cancer, Data and the Fallacy of the $1000 Genome – Forbes

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend